Navigation Links
Study seeks to halt progression of diabetic nephropathy
Date:3/14/2011

AUGUSTA, Ga. Researchers at Georgia Health Sciences University are studying whether inhibiting an enzyme that reduces levels of a protective metabolite could halt the progression of diabetic nephropathy, or kidney disease resulting from diabetes.

With a four year, $308,000 grant from the American Heart Association, Dr. Ahmed Elmarakby, Assistant Professor of Oral Biology in the College of Dental Medicine and Pharmacology and Toxicology in the Medical College of Georgia, will study how epoxyeicosatrienoic acids, or EETs, protect the kidneys.

EETs are metabolites that guard against inflammation and high blood pressure, very useful assets considering that oxidative stress and inflammatory cytokines play a role in diabetic nephropathy.

Elmarakby hypothesizes that EETs protect kidneys by inhibiting nuclear factor kappa B from signaling inflammation and by activating hemeoxygenase-1 to counteract oxidative damage.

But while EETs are working hard to protect the kidneys, an enzyme, soluble epoxide hydrolase, causes EETs to rapidly degrade in the body. Elmarakby believes drugs that inhibit the enzyme could halt the damage, and he is testing the theory on diabetic animals.

"Diabetic nephropathy is a leading cause of end-stage renal disease, for which the only treatment now is dialysis and kidney transplant," Elmarakby said. "We hope the inhibitors could potentially be used to halt the progression of renal injury during diabetes."

About 170 million people worldwide have diabetes, and that number is expected to double within the next 25 years. Diabetic nephropathy affects about 35 percent of diabetic patients.


'/>"/>

Contact: Paula Hinely
phinely@georgiahealth.edu
706-721-3646
Georgia Health Sciences University
Source:Eurekalert  

Page: 1

Related medicine news :

1. Neuro signals study gives new insight into brain disorders
2. Text Messages May Help Smokers Kick the Addiction, Small Study Finds
3. Adults With HIV at Increased Risk of Bone Fractures, Study Finds
4. New study shows government spending preferences of Americans
5. Wayne State study links testosterone with mens ability to woo potential mates
6. Depression Seems to Increase Risk of Kidney Failure: Study
7. UTHealth study: Stem cells may provide treatment for brain injuries
8. Humans Age at Same Pace as Other Primates, Study Finds
9. Poor Diet in Pregnancy Tied to Disease in Offspring: Rat Study
10. Animal Study May Explain Low Birth Weight-Obesity Link
11. Hopkins Childrens study finds some patients with cerebral palsy have asymmetric pelvic bones
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study seeks to halt progression of diabetic nephropathy
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... Charlotte, NC (PRWEB) , ... December 08, 2016 ... ... repeal Medicare and the Affordable Care Act. Dr. Botelho advocates for the mass ... A story movement gives people ongoing opportunities to share their unfortunate experiences; such ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... serve communities in and around the greater Phoenix metropolitan region, is announcing a ... , The mission of the Homeless Youth Connection is to promote community awareness ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a simple, ... and tightening the skin of the face to create more youthful features. While ... very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure that ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Mederi Therapeutics Inc . anunciou aprovação regulatória, pela CFDA, e lançamento de produto ... gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... performed and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun ... , , ...
(Date:12/8/2016)... LAVAL, Quebec , Dec. 8, 2016 /PRNewswire/ ... and TSX: VRX) ("Valeant") today announced positive ... vehicle-controlled clinical study to assess the safety and ... in the treatment of plaque psoriasis. ... adult subjects with moderate to severe psoriasis, IDP-118 ...
(Date:12/8/2016)... 2016 Information products and services provider ... Scopus , the world,s largest abstract and citation database of ... for journals from over 5,000 publishers. The new set of metrics ... to and when to adjust a journal,s editorial strategy. ... , , ...
Breaking Medicine Technology: